POZ - Latino Hub : Treatment News : HIV Lipo Treatment Egrifta to Be Reviewed May 27

POZ Latino / Hispanic Hub
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:
 

Back to home » News & Views » Treatment News


 

March 2011
February 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007


emailrssprint

March 22, 2010

HIV Lipo Treatment Egrifta to Be Reviewed May 27

A U.S. Food and Drug Administration (FDA) independent advisory committee is set to review Montreal-based Theratechnologies’ New Drug Application (NDA) for Egrifta (tesamorelin) for the treatment of HIV-associated fat increases (lipohypertrophy), according to an announcement from the Office of the Federal Register. The meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) to review the supporting safety and efficacy data is scheduled for May 27 at the University of Maryland University College in Adelphi.

Should EMDAC recommend Egrifta be approved, the FDA has until the end of July to decide whether to grant marketing clearance for the drug. Though the agency is not required to follow the recommendations of its advisory committees, it usually does.

Egrifta prompts the pituitary gland to release more growth hormone, which has been shown to promote fat loss in people with lipohyertrophy. Two completed Phase III clinical trials of Egrifta showed a decrease in visceral adipose tissue (VAT)—fat deep within the belly—of up to 18 percent and a favorable side effect profile.

Should the FDA approve Egrifta, EMD Serono of Rockland, Massachusetts, will assume full responsibility for marketing and selling the drug in the United States. Theratechnologies has retained the rights to sell the drug elsewhere in the world.

Theratechnologies submitted its NDA to the FDA on May 29, 2009. The agency filed it August 12, 2009, which initiated a substantive review of the application. The EMDAC meeting was originally scheduled for February 24, 2010, but was postponed due to administrative delays at the FDA. As a result, the FDA has indicated that the action goal date, which is the target date for the FDA to complete its review of the Egrifta NDA, will be extended to July 27 of this year.

NEW! Scroll down to comment on this story.

emailrssprint

 

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

  comments 1 - 3 (of 3 total)    

thuly, pietemaritzburg, 2010-05-20 12:33:54
i heard the lipo treament will available in US bt we also suffering in SA Please dont forget us i was very well structured nd pretty but now i lost all fat i only huge tummy i dnt knw what size im wearing bt my arms legs etc are thin

Jessica, , 2010-03-23 13:24:19
What I want to know is will this drugs also help with fat loss in face, and limbs?

J. Combs, Gaithersburg, MD, 2010-03-23 12:29:05
YES YES!! I hope this will work, I am so miserable with the deposits behind my stomach. I have no body fat whatsover according to my PCP and Digestive MD. And even tho' I am 6'5" tall, I weigh only 203, but I look like I am 8 months pregnant. And I know my wife would love to be able to use is, as she is 5"5" and weighs 140, with all of is below her stomach. We're both miserable like this, and we can only imagine how other are who have the fat deposits in other areas that are just uncomfortable

comments 1 - 3 (of 3 total)    


[Go to top]

Protesters hold the Hershey Company and its affiliated school accountable for condoning HIV-related discrimination. Click here to read more.
What to do if you've just been diagnosed
Qué hacer si eres recién diagnosticado

How to find a support system
Cómo encontrar un sistema de apoyo

Things you should know before starting treatment
Cosas que deberías saber antes de comenzar un tratamiento

How to handle side effects and other concerns
Cómo tratar los efectos secundarios y otros problemas de salud

How to tell someone you have HIV/AIDS
Cómo revelar tu diagnóstico de VIH/SIDA
[an error occurred while processing this directive]
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.